Market Overview

The Medicines Company, Alnylam Announce Global Alliance

Related MDCO
25 Stocks Moving In Thursday's Pre-Market Session
Medicines Company Gets FDA Approval, Has 119% Upside According To This Analyst

Medicines Company (NASDAQ: MDCO) and Alnylam
Pharmaceuticals (NASDAQ: ALNY) announced today that they have formed
an exclusive global alliance for the development and commercialization
of Alnylam's ALN-PCS RNAi therapeutic program for the treatment of

“This new alliance unites two organizations with a shared culture and
commitment to innovation. In my view and past experience, there could be
no stronger partner for our ALN-PCS program than The Medicines Company,
which has demonstrated industry-wide leadership in the advancement of
cardiovascular medicines to patients and remarkable success in its
strategy of in-licensing, developing, and commercializing breakthrough

See full press release

Posted-In: Earnings News Guidance Contracts Management


Related Articles (ALNY + MDCO)

View Comments and Join the Discussion!

Partner Center